131 related articles for article (PubMed ID: 8207666)
1. Iron supply of Pasteurella multocida and Pasteurella haemolytica.
Reissbrodt R; Erler W; Winkelmann G
J Basic Microbiol; 1994; 34(1):61-3. PubMed ID: 8207666
[TBL] [Abstract][Full Text] [Related]
2. [Investigation of outer membrane proteins of Pasteurella. 2: Iron-regulated outer membrane proteins of Pasteurella multocida and Pasteurella haemolytica].
Geschwend G; Feist H; Erler W
Berl Munch Tierarztl Wochenschr; 1997 Oct; 110(10):386-90. PubMed ID: 10084945
[TBL] [Abstract][Full Text] [Related]
3. Proximity-dependent inhibition of growth of Mannheimia haemolytica by Pasteurella multocida.
Bavananthasivam J; Dassanayake RP; Kugadas A; Shanthalingam S; Call DR; Knowles DP; Srikumaran S
Appl Environ Microbiol; 2012 Sep; 78(18):6683-8. PubMed ID: 22798357
[TBL] [Abstract][Full Text] [Related]
4. The response of Mannheimia haemolytica to iron limitation: implications for the acquisition of iron in the bovine lung.
Roehrig SC; Tran HQ; Spehr V; Gunkel N; Selzer PM; Ullrich HJ
Vet Microbiol; 2007 Apr; 121(3-4):316-29. PubMed ID: 17240088
[TBL] [Abstract][Full Text] [Related]
5. Biotinylated proteins of Pasteurella multocida and Pasteurella haemolytica cause false-positive reactions with biotinylated probes in colony lift-hybridization assays.
Register KB
Anal Biochem; 1998 Mar; 257(2):230-3. PubMed ID: 9514790
[No Abstract] [Full Text] [Related]
6. A large potentiation effect of serum on the in vitro potency of tulathromycin against Mannheimia haemolytica and Pasteurella multocida.
Lees P; Illambas J; Potter TJ; Pelligand L; Rycroft A; Toutain PL
J Vet Pharmacol Ther; 2017 Oct; 40(5):419-428. PubMed ID: 27891615
[TBL] [Abstract][Full Text] [Related]
7. Pasteurella multocida- and Pasteurella haemolytica-ghosts: new vaccine candidates.
Marchart J; Dropmann G; Lechleitner S; Schlapp T; Wanner G; Szostak MP; Lubitz W
Vaccine; 2003 Sep; 21(25-26):3988-97. PubMed ID: 12922135
[TBL] [Abstract][Full Text] [Related]
8. A minimal medium for growth of Pasteurella multocida.
Jablonski PE; Jaworski M; Hovde CJ
FEMS Microbiol Lett; 1996 Jul; 140(2-3):165-9. PubMed ID: 8764479
[TBL] [Abstract][Full Text] [Related]
9. Differential susceptibility to tetracycline, oxytetracycline and doxycycline of the calf pathogens Mannheimia haemolytica and Pasteurella multocida in three growth media.
Mead A; Lees P; Mitchell J; Rycroft A; Standing JF; Toutain PL; Pelligand L
J Vet Pharmacol Ther; 2019 Jan; 42(1):52-59. PubMed ID: 30267412
[TBL] [Abstract][Full Text] [Related]
10. DEVELOPMENT OF THE METHOD FOR IDENTIFICATION AND GENOTYPING OF THE BACTERIA PASTEURELLA MULTOCIDA AND MANNHEIMIA HAEMOLYTICA ON THE BASIS OF THE PCR AND PHYLOGENETIC ANALYSIS OF BACTERIAL CULTURES ISOLATED FROM CATTLE.
Nefedchenko AV; Shikov AN; Glotov AG; Glotova TI; Ternovoy VA; Agafonov AP; Sergeev AN; Donchenko NA
Mol Gen Mikrobiol Virusol; 2016 Sep; 34(2):62-66. PubMed ID: 30380208
[TBL] [Abstract][Full Text] [Related]
11. [Long-chain fatty acids of Pasteurella multocida nad Pasteurella haemolytica].
Erler W; Schimmel D; Steinbach G
Berl Munch Tierarztl Wochenschr; 1997 Oct; 110(10):365-8. PubMed ID: 10084940
[TBL] [Abstract][Full Text] [Related]
12. New interpretive criteria for danofloxacin antibacterial susceptibility testing against Mannheimia haemolytica and Pasteurella multocida associated with bovine respiratory disease.
Sweeney MT; Papich MG; Watts JL
J Vet Diagn Invest; 2017 Mar; 29(2):224-227. PubMed ID: 28064562
[TBL] [Abstract][Full Text] [Related]
13. Growth of Mannheimia haemolytica: inhibitory agents and putative mechanism of inhibition.
Kugadas A; Poindexter J; Lee ML; Bavananthasivam J; Call DR; Brayton KA; Srikumaran S
Vet Microbiol; 2014 Nov; 174(1-2):155-62. PubMed ID: 25246231
[TBL] [Abstract][Full Text] [Related]
14. Mutual antagonism between Mannheimia haemolytica and Pasteurella multocida when forming a biofilm on bovine bronchial epithelial cells in vitro.
Boukahil I; Czuprynski CJ
Vet Microbiol; 2018 Mar; 216():218-222. PubMed ID: 29519520
[TBL] [Abstract][Full Text] [Related]
15. Species selectivity of new siderophore-drug conjugates that use specific iron uptake for entry into bacteria.
Diarra MS; Lavoie MC; Jacques M; Darwish I; Dolence EK; Dolence JA; Ghosh A; Ghosh M; Miller MJ; Malouin F
Antimicrob Agents Chemother; 1996 Nov; 40(11):2610-7. PubMed ID: 8913474
[TBL] [Abstract][Full Text] [Related]
16. [Detection of atypical toxin-producing Pasteurella strains on the nasal mucosa of calves and their differential diagnostic limits for Pasteurella haemolytica and Pasteurella multocida].
Krüger M; Zucker B; Flegel T; Horst I; Grund S; Horsch F
Berl Munch Tierarztl Wochenschr; 1994 Jan; 107(1):15-9. PubMed ID: 8129703
[TBL] [Abstract][Full Text] [Related]
17. Coinfection with BHV-1 modulates cell adhesion and invasion by P. multocida and Mannheimia (Pasteurella) haemolytica.
Galdiero M; Pisciotta MG; Marinelli A; Petrillo G; Galdiero E
New Microbiol; 2002 Oct; 25(4):427-36. PubMed ID: 12437222
[TBL] [Abstract][Full Text] [Related]
18. Construction of conjugative shuttle and suicide vectors for Pasteurella haemolytica and P. multocida.
Azad AK; Coote JG; Parton R
Gene; 1994 Jul; 145(1):81-5. PubMed ID: 8045428
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic-pharmacodynamic integration and modelling of oxytetracycline for the calf pathogens Mannheimia haemolytica and Pasteurella multocida.
Lees P; Potter T; Pelligand L; Toutain PL
J Vet Pharmacol Ther; 2018 Feb; 41(1):28-38. PubMed ID: 28736817
[TBL] [Abstract][Full Text] [Related]
20. Tetracycline resistance determinants, Tet B and Tet M, detected in Pasteurella haemolytica and Pasteurella multocida from bovine herds.
Chaslus-Dancla E; Lesage-Descauses MC; Leroy-Sétrin S; Martel JL; Lafont JP
J Antimicrob Chemother; 1995 Nov; 36(5):815-9. PubMed ID: 8626262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
